The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Very interesting company for a long run buy. Great prospects as a company. Genome sequencing will only become more popular over the next few years and Ilumina is the leader in this field. As they make advances in this field driving down the price it will become more affordable to everyday people and soon be an essential part of modern healthcare as genome sequencing can be very useful as a preventative measure for almost all major illnesses.